Filing Details
- Accession Number:
- 0001415889-24-008316
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-18 17:40:14
- Reporting Period:
- 2019-09-10
- Accepted Time:
- 2024-03-18 17:40:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1759425 | Mirum Pharmaceuticals Inc. | MIRM | Pharmaceutical Preparations (2834) | 831281555 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1780347 | Lara Longpre | C/O Mirum Pharmaceuticals, Inc. 950 Tower Lane, Suite 1050 Foster City CA 94404 | Chief Development Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-09-10 | 965 | $10.64 | 105,372 | No | 4 | P | Direct | |
| Common Stock | Disposition | 2023-01-09 | 1,003 | $20.62 | 104,369 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | S | Direct |
Footnotes
- The weighted average purchase price for the transaction reported was $10.64, and the range of prices were between $10.20 and $10.8799. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
- Shares sold to cover tax witholding obligations associated with the vesting of restricted stock units.
Billionaire Hedge Funds
